Mastitis therapy and pharmacology.
Mastitis remains the most frequent cause of antibacterial use on dairy farms and contributes to a substantial portion of total drug and veterinary costs incurred by the dairy industry. Ultimately, the best outcome of mastitis therapy is a positive effect on the amount of marketed milk harvested and long-term survival of the cow. This article describes the strategies of therapy for bovine mastitis, with an emphasis on antibacterial and anti-inflammatory therapy.
Erskine
Ronald J
RJ
Department of Large Animal Clinical Science, College of Veterinary Medicine, D-202 VMC, Michigan State University, East Lansing, MI 48824, USA. erskine@cvm.msu.edu
Wagner
Sarah
S
DeGraves
Fred J
FJ
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002417:Cattle; D004305:Dose-Response Relationship, Drug; D005260:Female; D008414:Mastitis, Bovine / Q000188:drug therapy*; D008892:Milk / Q000166:cytology / Q000382:microbiology / Q000592:standards; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents